FEHID MEHIC: Open Payments
NPI 1538539929 · EAST SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,115 in 62 payments from 11 companies in 2025. Trend: 2023 $436 · 2024 $775 · 2025 $1,115
Food & beverage: $1,115
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 18 | $296 |
| ABBVIE INC. | 10 | $208 |
| Alkermes, Inc. | 8 | $151 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $100 |
| Teva Pharmaceuticals USA, Inc. | 6 | $95 |
| Janssen Pharmaceuticals, Inc | 3 | $67 |
| Collegium Pharmaceutical, Inc. | 3 | $56 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| Lundbeck LLC | 2 | $42 |
| Supernus Pharmaceuticals, Inc. | 2 | $29 |
Products named: COBENFY, VRAYLAR, ARISTADA, TRINTELLIX, AUSTEDO XR, REXULTI, Jornay PM, SPRAVATO.
Industry payments across NY — which companies pay providers there.
